Cargando…

Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children

BACKGROUND: Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Muenchhoff, Maximilian, Adland, Emily, Roider, Julia, Kløverpris, Henrik, Leslie, Alasdair, Boehm, Stephan, Keppler, Oliver T, Ndung’u, Thumbi, Goulder, Philip J R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467189/
https://www.ncbi.nlm.nih.gov/pubmed/30624717
http://dx.doi.org/10.1093/infdis/jiy668
_version_ 1783411239583481856
author Muenchhoff, Maximilian
Adland, Emily
Roider, Julia
Kløverpris, Henrik
Leslie, Alasdair
Boehm, Stephan
Keppler, Oliver T
Ndung’u, Thumbi
Goulder, Philip J R
author_facet Muenchhoff, Maximilian
Adland, Emily
Roider, Julia
Kløverpris, Henrik
Leslie, Alasdair
Boehm, Stephan
Keppler, Oliver T
Ndung’u, Thumbi
Goulder, Philip J R
author_sort Muenchhoff, Maximilian
collection PubMed
description BACKGROUND: Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART. METHODS: We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and memory phenotype markers and studied proliferative responses after antigen stimulation. RESULTS: We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively). CONCLUSIONS: Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-infected patients on ART with insufficient immune reconstitution.
format Online
Article
Text
id pubmed-6467189
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64671892019-04-19 Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children Muenchhoff, Maximilian Adland, Emily Roider, Julia Kløverpris, Henrik Leslie, Alasdair Boehm, Stephan Keppler, Oliver T Ndung’u, Thumbi Goulder, Philip J R J Infect Dis Major Articles and Brief Reports BACKGROUND: Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART. METHODS: We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and memory phenotype markers and studied proliferative responses after antigen stimulation. RESULTS: We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively). CONCLUSIONS: Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-infected patients on ART with insufficient immune reconstitution. Oxford University Press 2019-05-01 2019-01-08 /pmc/articles/PMC6467189/ /pubmed/30624717 http://dx.doi.org/10.1093/infdis/jiy668 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Major Articles and Brief Reports
Muenchhoff, Maximilian
Adland, Emily
Roider, Julia
Kløverpris, Henrik
Leslie, Alasdair
Boehm, Stephan
Keppler, Oliver T
Ndung’u, Thumbi
Goulder, Philip J R
Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title_full Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title_fullStr Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title_full_unstemmed Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title_short Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children
title_sort differential pathogen-specific immune reconstitution in antiretroviral therapy-treated human immunodeficiency virus-infected children
topic Major Articles and Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467189/
https://www.ncbi.nlm.nih.gov/pubmed/30624717
http://dx.doi.org/10.1093/infdis/jiy668
work_keys_str_mv AT muenchhoffmaximilian differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT adlandemily differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT roiderjulia differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT kløverprishenrik differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT lesliealasdair differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT boehmstephan differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT kepplerolivert differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT ndunguthumbi differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren
AT goulderphilipjr differentialpathogenspecificimmunereconstitutioninantiretroviraltherapytreatedhumanimmunodeficiencyvirusinfectedchildren